By Lisa Blumberg, JD

In late 2023, the National Institute on Minority Health and Health Disparities (NIMHD), designated people with disabilities as a population with health disparities for research supported by the National Institutes of Health (NIH). This means that NIMHD now recognizes that people with disabilities as a group experience significant disparities in their rates of illness, morbidity, mortality and survival, driven by social disadvantage, compared to the health status of the general population (italics mine for emphasis). Other NIH-designated populations with health disparities include racial and ethnic minority groups, people with lower socioeconomic status, underserved rural communities and sexual and gender minority groups (NIMHD is one of the institutes comprising NIH),
NIMHD’s decision, which was arrived at after some controversary, reflects both the input of disability rights activists and scientific evidence. As NIMHD director, Dr. Eliseo J. Pérez-Stable stated, “People with disabilities often experience a wide and varying range of health conditions leading to poorer health and shorter lifespan. In addition, discrimination, inequality and exclusionary structural practices, programs and policies inhibit access to timely and comprehensive health care, which further results in poorer health outcomes. People with disabilities who also belong to one or more other populations with health disparities fare even worse.”
The designation is an acknowledgement that anti-disability bias is a force undermining the health of disabled people in the U.S. and so the health of the country.
Steeped in the medical model, NIH has always funded research into treatments for conditions resulting in disabilities. Now it will also fund research into the myriad barriers disabled people face in achieving equal access to health care and how these barriers can be eradicated. For example, simultaneously with the announcement of the designation, NIH issued a notice of funding opportunity calling for research applications focused on novel and innovative approaches and interventions that address the intersecting impact of disability, race and ethnicity, and socioeconomic status on healthcare access and health outcomes.
The social model of disability has come to the bastion of medical research.
“This is a big deal,” said Peter W. Thomas, co-coordinator of the Disability and Rehabilitation Research Coalition, which focuses on improving disability research.
Writing in Stat, Lynne Moronski, a health care researcher and parent of a daughter with significant disabilities, called the designation a landmark decision.
Joel Reynolds in a recent piece in JAMA Health Forum called it a watershed moment. He went on to say, “medicine is indeed at the beginning of appreciating the problem of ableism in medicine, the beginning of making equity of care for disabled patients a priority, and the beginning of not just acknowledging, but mitigating and eliminating the health disparities faced by disabled people. This beginning promises a future that improves quality and equity of care across patient populations, builds better health care systems, and makes a world that is a better fit for all.”
The action by the NIH and the updating of the 504 regulations to prohibit discrimination based on disability by health care providers receiving federal funds are victories for disability activists. Nonetheless, we still face threats. The medical system continues to be inefficient, fragmented and profit driven. The “better dead than disabled” ethos is virulent and, as discussed in a future blog, it underlies much of the agitation for legalized assisted suicide and euthanasia. It is the best of times. It is the worst of times.